(Q43053409)

13 November 2017

title

Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients (English)

1 reference

13 November 2017

0 references

1

1 reference

13 November 2017

2

1 reference

13 November 2017

8

1 reference

13 November 2017

9

1 reference

13 November 2017

10

1 reference

13 November 2017

3

Sibilla A T Salvadeo

1 reference

13 November 2017

4

Ilaria Ferrari

1 reference

13 November 2017

5

Alessia Gravina

1 reference

13 November 2017

6

Roberto Mereu

1 reference

13 November 2017

7

Ilaria Palumbo

1 reference

13 November 2017

language of work or name

1 reference

27 May 2010

1 reference

13 November 2017

published in

Hypertension Research

1 reference

13 November 2017

volume

33

1 reference

13 November 2017

issue

8

1 reference

13 November 2017

page(s)

790-795

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.85

13 November 2017

exact match

0 references

cites work

Improvement of insulin sensitivity by antagonism of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

Obesity, essential hypertension and renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Local adipose tissue renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Angiotensin inhibition stimulates PPARgamma and the release of visfatin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Adipocytokines and the metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Retinol binding protein-4 levels and clinical features of type 2 diabetes patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Candesartan effect on inflammation in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Neuroendocrine and metabolic effects of adipocyte-derived hormones

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Abnormal glucose homeostasis due to chronic hyperresistinemia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Resistin is an inflammatory marker of atherosclerosis in humans.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Medicine. Visfatin: a new adipokine

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Insulin Resistance, Inflammatory Biomarkers, and Adipokines in Patients with Chronic Kidney Disease: Effects of Angiotensin II Blockade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.85

7 January 2021

Identifiers

DOI

10.1038/HR.2010.85

1 reference

13 November 2017

1 reference